Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Ingmar Hoerr appointed advisor to European Commission

Country: Germany

Ingmar Hoerr, chief executive of CureVac AG, has been appointed as one of 15 members of a new group that will advise the European Commission on strengthening the environment for research and innovation in the European Union.

Read more

Consultation on EU capital market reform

Country: Belgium

A proposed liberalisation of rules that govern financial transactions in the European Union is the subject of a public consultation that started on 20 January and will continue until 17 March. The consultation is being managed by the European Commission.

Read more

Cross-consent accord for Charpentier IP

Country: Ireland

Read more

Immatics in bispecific deal with Amgen

Country: Germany

Read more

Macrophage Pharma secures funding

Country: United Kingdom

Read more

Eternygen raises €8 million for metabolic drugs

Country: Germany

Read more

Reshaping of Medivir completed

Country: Sweden

Read more

Enterome starts trial of microbiome drug

Country: France

Read more

NeRRe gets capital for early-stage drugs

Country: United Kingdom

Read more

RondinX launches microbiome analysis tool

Country: Israel

Read more

Versant poised for biotech investments

Country: United States

Read more

Chiesi and Aptuit to research fibrosis

Country: Italy

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

The outlook for T cell immunotherapies by Stefanos Theoharis

TcellimmunotherapiesStefanosTheoharisJan2017.pdf

Highlights of the January 2017 MedNous issue

The January 2017 MedNous features:

Latest Mednous cover
  • Oncology Review
    Cancer repertoire enlarged in 2016
    By Bruno Pagliara
  • Commentary
    Promising outlook for T cell immunotherapies
    By Stefanos Theoharis
  • Financial Strategy
    Versant Ventures expands in Europe
    Interview with Bradley Bolzon
  • Stock Market Review
    How risky are European biotechs?
  • The Unitary Patent
    Brexit and patent reform
    By Beatriz San Martin and Chris Leung
  • Meeting Report
    Optimism at JP Morgan
    By Robin Davison

The latest MedNous journal. Subscribe to download.